Medical robotics for early mobilisation for critical care patients
Reactive Robotics developed AI-driven robotic assistance system for the early mobilisation of ICU patients.
Their robotic system guarantees early mobilisation is delivered safely to all ICU patients, accelerating recovery by 20%, reducing treatment costs, increasing ICU capacity by 27%, and improving patient outcomes.
Developing drugs for undruggable conditions
ProSion created a drug discovery platform building new drugs from molecules.
Their technology uses LEGO-like chemical building blocks to develop new and effective drugs for hard-to-treat diseases–such as aggressive cancer forms.
Creating antimicrobials for future pandemics
Omnix Medical is developing an arsenal of novel antibiotic agents for the treatment of infections involving drug-resistant bacteria.
Their drug discovery pipeline is based on natural antimicrobial peptides, genetically engineered to be compatible with therapeutic use.
Leader of electrotherapeutic solutions for bone and tissue regeneration
Intelligent Implants creates data-enabled and minimally-invasive medical implants for active monitoring and therapy.
Their medical devices enable the tailoring of treatments to patient needs and facilitate decision-making for healthcare professionals.
Graphene-based neural interfaces for the treatment of neurological diseases
INBRAIN Neuroelectronics develops a complete platform of intelligent neuroelectronic interface systems powered by Graphene dots.
Their graphene-based neural implants will have the capability of reading single neural cells, detecting therapy-specific biomarkers and triggering adaptive responses for increased outcomes in personalised neurological therapies.
AI-enabled Intelligent lab on fibre for identification and quantification of disease biomarkers
iLoF is pioneering an AI-based platform to accelerate the future of personalised drug discovery & development.
Their technology uses advanced AI & photonics to detect label-free nanosized biomarkers in biological liquid samples, to generate specific patient or disease signatures for drug discovery purposes.
Harnessing the power of AI for cardiovascular drug discovery
Genome Biologics Integrates AI-driven target and drug identification with preclinical testing enabling faster drug discovery informed by data.
They focus on developing new cardioprotectives that can protect the hearts of cancer patients treated with chemo.
Genomics-informed drug discovery for precision oncology
Epigene Labs focuses on discovering cancer treatments by leveraging advanced AI and genomic data in designing tailored therapeutic approaches.
Their platform enables both brand-new drug discovery & drug repurposing for the largest patient benefit.
Vaginal Microbiome Screening service to provide diagnosis, disease risk evaluation, and aftercare
Daye is set to revolutionise women's healthcare by providing a home-based gynaecological test kit for testing for STIs, infections and HPV.
Their patent-protected technology enables DNA extraction to test 16 different biomarkers simultaneously to offer comprehensive aftercare, including treatment planning & doctor consultations.
+32 6 98 100 87
+44 20 3286 2807
+41 315 190 109
+65 9779 1309